Načítá se...
Longitudinal Evaluation of Lipoprotein Parameters in Systemic Lupus Erythematosus Reveals Adverse Changes with Disease Activity and Prednisone and More Favorable Profiles with Hydroxychloroquine Therapy
OBJECTIVES: Systemic lupus erythematosus (SLE) associates with accelerated atherosclerotic cardiovascular disease. SLE patients have adverse lipoprotein parameters, but little is known about how these change with treatment and disease activity. The NMR LipoProfile test(®) contains a glycoprotein sig...
Uloženo v:
| Vydáno v: | J Rheumatol |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4818734/ https://ncbi.nlm.nih.gov/pubmed/26834214 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3899/jrheum.150437 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|